All returns in this analysis are measured from the disclosure date forward, and the public could have seen each of these positions when they were filed. Rep. Ro Khanna's purchase of MRNA, disclosed on January 6 2026, is an outlier we are still verifying. Likewise, Rep. Lisa McClain's buy of SNDK, disclosed on November 21 2025, is an outlier we are still verifying.
Among the verified trades, Rep. Ro Khanna disclosed his MU purchase on November 6 2025, which has returned 457.22 percent since filing. Rep. Tim Moore's TZA buy, disclosed July 9 2025, has gained 305.85 percent. Rep. Lisa McClain's ROIV position, filed on August 13 2025, stands at a 254.59 percent return. Rep. Gilbert Cisneros disclosed his SEI buy on June 6 2025, posting an 184.16 percent gain since then. These filings spanned healthcare, technology and energy sectors, with the TZA position reflecting a leveraged bearish stance on small caps that aligned with subsequent market moves.
The pattern shows certain disclosed buys by these four members produced results that became apparent only after the mandatory reporting window, offering retail investors a transparent window into ideas that later delivered substantial alpha. MU and ROIV in particular benefited from sector tailwinds in semiconductors and biotech innovation, while SEI rode energy infrastructure strength. What stands out in the latest data is the clustering of these outperformers across just a handful of lawmakers, with verified gains holding even as some shorter-term metrics show pullbacks.
This performance does not recur uniformly and reflects specific market conditions over holding periods ranging from 379 to 730 days. Tracking disclosures promptly after release can surface ideas, yet individual results depend on execution and timing. Broader market trends, including sector rotations in tech and healthcare, provide important context for these outcomes.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.